Healthcare providers' expected barriers and facilitators to the implementation of person‐centered long‐term follow‐up care for childhood cancer survivors: A <scp>PanCareFollowUp</scp> study
Dionne Breij(Radboud University Nijmegen), Rosella Hermens(Radboud University Nijmegen), Gisela Michel(University of Lucerne), Iridi Stollman(Radboud University Nijmegen), Roderick Skinner(Royal Victoria Infirmary), Riccardo Haupt(Istituto Giannina Gaslini), Irene Göttgens(Radboud University Nijmegen), Tomáš Kepák(Masaryk University), Jeanette Falck Winther(Erasmus MC), Iris Walraven(Radboud University Nijmegen), Monica Muraca(Istituto Giannina Gaslini), Leontien C.M. Kremer(Emma Kinderziekenhuis), Hannah Gsell, Eline Bouwman(Radboud University Nijmegen), Katharina Roser(University of Lucerne), Anne Uyttebroeck(Inserm), Kateřina Kepáková(Masaryk University), Cecilia Follin(Lund University), Saskia M. F. Pluijm(Princess Máxima Center), Marleen Renard, Lars Hjorth(Lund University), Jaqueline Loonen(Radboud University Nijmegen), Nicole Blijlevens(Radboud University Nijmegen), Anita Kienesberger, Helena J. H. van der Pal
Cited by 8
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|The Lancet Oncology|2015|561
Cardioprotective interventions for cancer patients receiving anthracyclines
|Cochrane Database of Systematic Reviews|2011|553